RNA Analysis Market

Market Study on RNA Analysis: Growing influence of Real Time-PCR (qPCR) technology, Microarray Technology to propel RNA Analysis Market

RNA Analysis Market Segmented by Product Type (Instruments, Kits & Reagents - miRNA & siRNA | Reverse Transcriptases & RT-PCR | RNA Extraction & Purification | RNA Interference, Services), Technology (Real Time-PCR (qPCR) Technology, Microarray Technology, Sequencing Technology) in North America, Europe, APAC, Middle East & Africa Region

Report ID: PMRREP33202

Number of Pages: 250

Format: PPT*, PDF, EXCEL

Industry: Healthcare

Published Date: November-2022

Report Price


Buy Now

RNA Analysis Market Outlook (2022-2032)

RNA Analysis Market analysis report by Persistence Market Research shows that global sales of RNA Analysis Market in 2021 was held at US$ 10.6 Bn. With 16.1%, the projected market growth during 2022 is expected to be significantly higher than the historical growth. Real Time-PCR (qPCR) Technology is expected to be the highest revenue-generating segment, projected to grow at a CAGR of over 17.2% during 2022 – 2032.



Global RNA Analysis Market (2022)

US$ 12.1 Bn

Global RNA Analysis Market (2032)

US$ 53.6 Bn

Global RNA Analysis Market CAGR (2022 – 2032)


North America RNA Analysis Market (2022)

US$ 3.9 Bn

U.S. RNA Analysis Market (2022)

US$ 3.6 Bn

Key Companies Profiled

  • Agilent Technologies Inc
  • Bio-Rad Laboratories Inc
  • F.Hoffman-La Roche Ltd
  • IllUMINA Inc
  • Thermo Fisher Scientific
  • Danaher Corporation
  • Lexogen GmbH
Sample Report

Report Sample is Available

In-depth report coverage is now just a few seconds away

Download PDF Get Report Sample

Revenue of RNA Analysis Market from 2017 to 2021 Compared to Demand Outlook for 2022 to 2032

As per the RNA Analysis Market research by Persistence Market Research - a market research and competitive intelligence provider, historically, from 2017 to 2021, market value of the RNA Analysis Market increased at around 13.9% CAGR. With an absolute dollar opportunity of US$ 41.5 Bn, the market is likely to reach a valuation of 53.6 Bn by 2032.

The RNA analysis market is growing due to the increased use of Real Time-PCR (qPCR) Technology for COVID-19 diagnoses worldwide in 2020. The technique is understood to be very sensitive and quantitative, making it one of the prospective ways for probing a small number of transcripts in huge samples. Real Time-PCR allows for the relatively high-sensitivity identification of SARS-CoV-2, the analysis of viral RNA in different types of clinical samples, the detection of SARS-CoV-2 mutations, and the assessment of anti-SARS-CoV-2 medicines. As a result, the COVID-19 acted as a motivator for the market.

Custom Report Cover

Make This Report Your Own

Take Advantage of Intelligence Tailored to your Business Objective

> Get a Customized Version

Which Factors are Propelling RNA Analysis Demand?

Rising demand for tailored medication in cancer treatment, as well as increased R&D spending in different technologies such as Real Time-PCR (qPCR) technology, Microarray Technology, and Sequencing Technology by pharmaceutical and biopharmaceutical firms, are driving the growth of the RNA analysis market. The increased emphasis on biomarker development and toxicogenomic research, as well as the growing interest in outsourcing services, are projected to present significant potential opportunities for global RNA analysis market participants.

The spectacular growth in both private and non-private investment may also provide incredible potential for the RNA analysis market over the projection period. The rising interest in outsourcing services, as well as the increased emphasis on biomarker development and toxicogenomic research, are projected to present significant growth opportunities for global market participants. The increasing rates of genetic alterations in genetic variations and carcinogens are compelling the RNA analysis industry to grow significantly.

Market Research Methodology

Market Research Methodology

-Perfect through Years of Diligence

Check Research Methodology

Which Region is projected to Offer the Largest Opportunity for RNA Analysis Market?

During the projected period, North America held the largest share in the global RNA Analysis Market with a market size of US$ 3.9 Bn in 2022. The market in the region is expected to grow at a CAGR of 16%. Because of the existence of a significant number of biotech enterprises with well-established infrastructure, the demand in North America is the highest.

Furthermore, the private sector's ongoing expansion in transcriptomics-related research and development expenditures enables regional market participants to produce tailored therapies. A significant proportion of this segment of the market can be attributed to the rising fast development of structure-based drug designs, increasing academics and government investment opportunities in genomics and proteomics research, rising life science research grants, high investment in biopharmaceutical R&D expenditure, increased emphasis on transcriptomics research, and larger development of innovative technologies in North America.

Due to the increasing rate of RNA Analysis expenditure in South Korea, Japan, and China and factors such as high investment in pharmaceutical and biopharmaceutical research and development, and product innovations related to RNA analysis, Asia Pacific is projected to grow at the fastest rate throughout the projection period.

Country-wise Analysis

U.S. RNA Analysis Market Assessment

The United States is expected to account for the largest RNA analysis market globally, valued at US$ 15.9 Bn by the end of 2032. Factors influencing market expansion include expanding investment opportunities, rising healthcare expenditures, and implementation of government programs.

Furthermore, the private sector's ongoing expansion in the pharmaceutical and biopharmaceutical market, constant technological advancements in different reagent kits related to RNA analysis to enhance commercialization, and rising illness instances such as Covid-19, hepatitis B, diabetes, and cancer are propelling the RNA analysis market expansion.

U.K. RNA Analysis Market Assessment

The RNA analysis market in the U.K. was valued at US$ 477 Mn in 2021. With an absolute dollar opportunity of US$ 2.3 Bn during 2022 – 2032, the market is projected to reach a valuation of US$ 2.8 Bn by 2032.

Japan RNA Analysis Market Assessment

In Japan, the RNA analysis market is projected to reach a valuation of US$ 2.1 bn by 2032, growing from US$ 470.4 Mn in 2022. The market is projected to witness an absolute dollar opportunity of US$ 1.6 Bn during 2022 – 2032.

South Korea RNA Analysis Market Assessment

RNA Analysis market in South Korea is projected to garner an absolute dollar opportunity of US$ 881.2 Mn during 2022 – 2032. The market is projected to reach a valuation of US$ 1.1 Bn by 2032, growing at a CAGR of 15.9% during 2022 – 2032.

Category-wise Insights

Why Revenue through Real Time-PCR (qPCR) Technology is Expected to Witness Fastest Growth?

Real Time-PCR (qPCR) Technology segment is forecasted to grow at the highest CAGR of over 17.2% during 2022-2032. With the increasing frequency of genetic abnormalities, revenues in RNA analysis market is likely to rise. Furthermore, factors such as the increasing demand for qPCR testing kits, technological advancements in this technology, and increased government support for research activities would aid market expansion.

This technology is widely used in medical laboratory research, with applications ranging from biological research to criminal forensics. The Covid-19 epidemic had a beneficial influence on qPCR technology which was widely used as a dependable and fast detection technology. Digital advancements and automation, as well as higher use of biomarkers in cancer diagnosis, have been driving the market.

Why is Kits & Reagents to Witness Fastest Growth among RNA Analysis Market by Product?

Kits & Reagents segment is forecasted to grow at the highest CAGR of over 16% during 2022-2032. The growing need for high-quality kits and reagents, as well as the frequent usage of medium and chemical products in RNA analysis has been augmenting the market growth.

Furthermore, rising research and development activities in the biopharmaceutical and pharmaceutical business, growing government spending in life science research, and high research with integrated omics studies are adding to the market for these consumables.

What is the impact of Covid-19 on RNA Analysis Market?

The COVID-19 pandemic sparked scientific interest due to efforts to better study the virus's dynamics. Scientists expect that the usage of qPCR technology and personalized medicine will grow steadily over the forthcoming years. SARS-CoV-2 has propelled the RNA sequencing industry to the forefront of attention, with significant demand for research and treatment of COVID-19.

As the number of COVID-19 cases increases drastically over the world, so does the demand for the healthcare system. Clinicians and scientists are using RNA sequencing significantly to interpret the genetic codes of SARS-CoV-2.

Competitive Analysis

The worldwide RNA Analysis Industry is expected to expand rapidly due to leading market players' continual strategic alliances and partnerships via agreements as well as targeted acquisitions and mergers. Due to technical improvements in different RNA analysis platform types and enhanced microarray technology, the global RNA Analysis market will also rise considerably throughout the projection period.

Some of the recent developments of key RNA Analysis service providers are as follows:

  • In April 2021, Qiagen announced the QIAseq DIRECT SARS-CoV-2 Kit, viral library preparation, and genomic enriching platform to decrease the usage of plastics and library turnaround times when contrasted with primer-based sequencing. The business introduced this solution to meet the growing need for high-throughput sequencing for the study and monitoring of emerging and more dangerous SARS-CoV-2 mutations.
  • In September 2021, Thermo Fisher Scientific introduced the TaqPath Covid-19 RNase P 2.0 test kit, which is CE-IVD marked. The new kit was modified to detect active SARS-CoV-2 by detecting the presence of any of the virus's eight gene targets. By screening numerous genes, it aids in giving reliable findings for both existing and future Covid-19 virus alterations. The TaqPath Covid-19 RNase P 2.0 kit, which has a three-hour turnaround time, employs a newly developed test for analyzing nasopharyngeal and oral or nasal swab samples to detect active Covid-19 cases.
  • In March 2021, Agilent Technologies, Inc. announced the completion of its takeover of Resolution Bioscience, a company involved in the development and marketing of next-generation sequencing (NGS)-based targeted oncology solutions. The adoption of Resolution Bioscience's liquid biopsy-based diagnostic technology will increase Agilent's capabilities to biopharma and clinical diagnostics clients and expand the company's diagnostics and genomics businesses. Agilent made a deal to pay US$ 550 million in cash at closing and up to an extra US$ 145 million contingent on meeting future performance objectives, according to the terms of the agreement.

Similarly, recent developments related to companies RNA Analysis Market have been tracked by the team at Persistence Market Research, which are available in the full report.

Market Segments Covered in RNA Analysis Market Analysis

By Product Type

  • Instruments
  • Kits & Reagents
    • miRNA & siRNA
    • Reverse Transcriptases & RT-PCR
    • RNA Extraction & Purification
    • RNA Interference
    • Others
  • Services

By Technology

  • Real Time-PCR (qPCR) Technology
  • Microarray Technology
  • Sequencing Technology
  • Others

By Application

  • Construction of RNA Expression Atlas
  • Epigenetics
  • Infectious Diseases and Pathogenesis
  • Alternative RNA Splicing
  • RNA Structure & Molecular Dynamics
  • Development & Delivery of RNA Therapeutics
  • Others

By End-use

  • Government Institutes & Academic Centers
  • Pharmaceutical & Biotechnology Companies
  • Contract Research Organizations (CROs)
  • Hospitals & Clinics

By Region

  • North America
  • Latin America
  • Europe
  • APAC
  • MEA

For report customisation and delivery information contact our sales representative.

Companies Covered in This Report

  • Agilent Technologies Inc
  • Bio-Rad Laboratories Inc
  • F.Hoffman-La Roche Ltd
  • IllUMINA Inc
  • Thermo Fisher Scientific
  • Danaher Corporation
  • Lexogen GmbH
  • Eurofins Scientific
  • Merck KGaA
  • Pacific Bioscience of California, Inc.
  • Affymetrix, Inc.
  • Promega

Frequently Asked Questions

At present, the market for RNA Analysis is valued at around US$ 10.6 billion.

The value of RNA Analysis Market is projected to increase at a CAGR of around 16.1% during 2022 - 2032.

The value of RNA Analysis Market increased at a CAGR of around 13.9% during 2017 - 2021.

Next-generation sequencing (NGS) and RNA interference (RNAi) technologies have enhanced precision and accuracy, allowing researchers to evaluate transcriptional activity, which is one of the prominent trends in the market.

The market for RNA Analysis Market in China is projected to expand at a CAGR of around 19.9% during 2022 - 2032.

While the market in South Korea is expected to grow at nearly 15.9%, the market in Japan is projected to register a CAGR of 16% during 2022 - 2032.

This site uses cookies, including third-party cookies, that help us to provide and improve our services. Privacy Policy
Google translate